MiS checkmates a chronic diabetic ulcer: a clinical case

12 October 2021 - Research

After having been tried and widely used for treating wounds with appreciable results, MLS® Laser Therapy with the MiS device provided positive results also when treating a chronic diabetic ulcer.

The simultaneous action of two different wavelengths with high peak power which characterise the equipment in fact produces analgesic, anti-inflammatory and anti-oedema effects which proved to be important for effectively managing the disease and for facilitating healing of both superficial and deep tissues.

This is confirmed by a 65-year old patient suffering from type 2 diabetes with a chronic ulcer to the right ankle caused by the disease. Initially undergoing drug therapy and dedicated surveillance with no appreciable results, the patient then underwent MLS® Laser Therapy: 20 sessions (4 per week lasting 2 minutes each) with the MiS device (“superficial wound” protocol), followed by simple medication, which after just a few sessions led to an evident improvement in the ulcer, up to its complete closure at the end of the cycle.

Furthermore, subsequent follow-ups at 1 and 2 months showed a full recovery of the skin barrier and the absence of inflammation.

Testo a Destra
Immagine 30%/Testo 60%
Ulcer wound healing with MiS laser device

“Healing of Leg Diabetic ulcer treated with MLS-MiS laser (MiS – MLS® High Peak Pulse): a case report”
T. Viliani, B. Lombardi
Energy For Health [21], 2021

READ MORE

You might also be interested in ...

See all articles

Energy for Health - Scientific review by ASAcampus
news - 01/10/2021
Four case reports dedicated to applying the MLS® therapy, two in the human field and two in the veterinary field are the focus of the new edition of Energy for Health.
Effect of NIR Laser Therapy by MLS‐MiS Source on Fibroblast Activation by Inflammatory Cytokines in Relation to Wound Healing
blog - 12/04/2021
The ASA device have an important anti-inflammatory effect, but it is also effective in controlling fibroblast activation induced by IL‐1β and TNF‐α, probably responsible for a detrimental effect on...
myelin thickness with MLS laser MiS
Research
L. Micheli, F. Cialdai, A. Pacini, J.J.V. Branca, L. Morbidelli, V. Ciccone, E. Lucarini, C. Ghelardini, M. Monici, L. Di Cesare Mannelli Nature Scientific Reports, 9:9297, 2019
MLS Laser Therapy for TMD
Blog - 22/10/2025
A recent publication from Chulalongkorn University (Thailand) demonstrated how an integrated and conservative approach, supported by MLS® Laser Therapy, can offer highly effective clinical results.
M-Hi laser training UK
News - 22/10/2025
From 30 September to 3 October, the tour visited three cities in the United Kingdom, involving physiotherapists and specialists who have chosen the M-Hi and HIRO TT laser systems.
Press - 07/10/2025
Recent research and pilot studies highlight the benefits of laser therapy in treating radiodermatitis and peripheral neuropathy induced by radiation and chemotherapy for breast cancer.